Analytical Data
-
Gene name
MARVELD3
- Application
-
Alternative Names
MARVELD3; MRVLDC3; MARVEL domain-containing protein 3
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96A59
-
Expression Region
1-401aa
-
AA Sequence
MEDPSGAREPRARPRERDPGRRPHPDQGRTHDRPRDRPGDPRRKRSSDGNRRRDGDRDPKRDQERDGNRDRNRDRERERERERDPDRGPRRDTHRDAGPRAGEHGVWEKPRQSRTRDGARGLTWDAAAPPGPAPWEAPEPPQPQRKGDPGRRRPESEPPSERYLPSTPRPGREEVEYYQSEAEGLLECHKCKYLCTGRACCQMLEVLLNLLILACSSVSYSSTGGYTGITSLGGIYYYQFGGAYSGFDGADGEKAQQLDVQFYQLKLPMVTVAMACSGALTALCCLFVAMGVLRVPWHCPLLLVTEGLLDMLIAGGYIPALYFYFHYLSAAYGSPVCKERQALYQSKGYSGFGCSFHGADIGAGIFAALGIVVFALGAVLAIKGYRKVRKLKEKPAEMFEF
-
Molecular Weight
71.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MARVELD3, a member of the MARVEL (MAL and Related proteins for Vesicle trafficking and Membrane link) domain-containing protein family, has garnered attention for its potential roles in cellular processes such as membrane trafficking and signal transduction. Research into MARVELD3 has emerged due to its unique structural features, which suggest it may be involved in the regulation of cellular homeostasis and protective mechanisms against various stressors. Studies have indicated that MARVELD3 plays a pivotal role in immune responses, cellular proliferation, and apoptosis, linking it to various disease states, including cancer and autoimmune disorders. Additionally, the potential involvement of MARVELD3 in the pathology of neurodegenerative diseases has prompted investigations into its therapeutic applications. The recombinant expression of MARVELD3 has enabled researchers to elucidate its functional properties and interactions with other cellular components. By producing MARVELD3 as a recombinant protein, scientists can better understand its biological significance and explore its potential as a target for novel therapeutic strategies. This research underscores the importance of MARVELD3 in cell biology and pathology, highlighting its potential as a biomarker or therapeutic target in disease contexts.
